Tectonic Therapeutic (TECX) Other financing activities (2018 - 2026)
Tectonic Therapeutic (TECX) posted quarterly Other financing activities of $100000.0 for Q1 2026, down 99.94% year-over-year from $177.3 million in Q1 2025, and up 102.4% quarter-over-quarter from -$4.2 million in Q2 2025.
Tectonic Therapeutic (TECX) Other financing activities (2018 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has reported Other financing activities for 9 consecutive years, with $100000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other financing activities fell 99.94% year-over-year to $100000.0; the TTM figure through Mar 2026 stood at -$4.1 million (down 102.27% YoY), while the FY2025 annual figure was $173.1 million, up 10558.74% from the prior year.
- Other financing activities rose to $100000.0 in Q1 2026 per TECX's latest filing, from -$4.2 million in the prior quarter.
- Across five years, Other financing activities topped out at $177.3 million in Q1 2025 and bottomed at -$4.2 million in Q2 2025.
- Historically, Other financing activities has averaged $22.0 million across 5 years, with a median of $110000.0 in 2023.
- Annual changes were most pronounced in 2024 — Other financing activities jumped 1253.33% — and 2025, when it tumbled 795.0%.
- Tectonic Therapeutic's Other financing activities stood at $58000.0 in 2022, then soared by 106.9% to $120000.0 in 2023, then surged by 1253.33% to $1.6 million in 2024, then sank by 356.77% to -$4.2 million in 2025, then surged by 102.4% to $100000.0 in 2026.
- Business Quant data shows TECX's Other financing activities at $100000.0 in Q1 2026, -$4.2 million in Q2 2025, and $177.3 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Tectonic Therapeutic | 671.50 Mn | 671.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.81 Mn |
| Jun 30, 2026 | 11.81 Mn |
| Mar 31, 2026 | 100,000.00 |
| Mar 31, 2026 | 100,000.00 |
| Jun 30, 2025 | -4.17 Mn |
| Jun 30, 2025 | -4.17 Mn |
| Mar 31, 2025 | 177.27 Mn |
| Mar 31, 2025 | 177.27 Mn |
| Dec 31, 2024 | 1.62 Mn |
| Dec 31, 2024 | 1.62 Mn |
| Jun 30, 2024 | 600,000.00 |
| Jun 30, 2024 | 600,000.00 |
| Dec 31, 2023 | 120,000.00 |
| Dec 31, 2023 | 120,000.00 |
| Mar 31, 2023 | 42,000.00 |
| Mar 31, 2023 | 42,000.00 |
| Dec 31, 2022 | 58,000.00 |
| Dec 31, 2022 | 58,000.00 |
| Dec 31, 2021 | 48,000.00 |
| Dec 31, 2021 | 48,000.00 |